ClinicalTrials.gov record
Terminated Phase 2Phase 3 Interventional

Study to Assess the Efficacy and Safety of Ublituximab + Umbralisib With or Without Bendamustine and Umbralisib Alone in Patients With Previously Treated Non-Hodgkins Lymphoma

ClinicalTrials.gov ID: NCT02793583

Public ClinicalTrials.gov record NCT02793583. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 2:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + Umbralisib With or Without Bendamustine and Umbralisib Alone in Patients With Previously Treated Non-Hodgkin's Lymphoma

Study identification

NCT ID
NCT02793583
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
TG Therapeutics, Inc.
Industry
Enrollment
710 participants

Conditions and interventions

Interventions

  • Bendamustine Biological
  • Ublituximab Biological
  • Umbralisib Drug

Biological · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 24, 2016
Primary completion
May 30, 2022
Completion
Jul 3, 2022
Last update posted
Jul 20, 2022

2016 – 2022

United States locations

U.S. sites
111
U.S. states
38
U.S. cities
100
Facility City State ZIP Site status
TG Therapeutics Investigational Trial Site Birmingham Alabama 35243
TG Therapeutics Investigational Trial Site Huntsville Alabama 35805
TG Therapeutics Investigational Trial Site Chandler Arizona 85224
TG Therapeutics Investigational Trial Site Tucson Arizona 85711
TG Therapeutics Investigational Trial Site Tucson Arizona 85724
TG Therapeutics Investigational Trial Site Los Angeles California 90095
TG Therapeutics Investigational Trial Site Orange California 92868
TG Therapeutics Investigational Trial Site San Diego California 90710
TG Therapeutics Investigational Trial Site San Diego California 92108
TG Therapeutics Investigational Trial Site Whittier California 90603
TG Therapeutics Investigational Trial Site Aurora Colorado 80012
TG Therapeutics Investigational Trial Site Denver Colorado 80218
TG Therapeutics Investigational Trial Site Fort Collins Colorado 80528
TG Therapeutics Investigational Trial Site Bridgeport Connecticut 06606
TG Therapeutics Investigational Trial Site Newark Delaware 19713
TG Therapeutics Investigational Trial Site Washington D.C. District of Columbia 20007
TG Therapeutics Investigational Trial Site Boca Raton Florida 33486
TG Therapeutics Investigational Trial Site Fort Myers Florida 33916
TG Therapeutics Investigational Trial Site Gainesville Florida 32608
TG Therapeutics Investigational Trial Site Jacksonville Florida 32204
TG Therapeutics Investigational Trial Site Jacksonville Florida 32224
TG Therapeutics Investigational Trial Site Jacksonville Florida 32256
TG Therapeutics Investigational Trial Site Miami Florida 33176
TG Therapeutics Investigational Trial Site St. Petersburg Florida 33705
TG Therapeutics Investigational Trial Site Tallahassee Florida 32308
TG Therapeutics Investigational Trial Site Tampa Florida 33612
TG Therapeutics Investigational Trial Site West Palm Beach Florida 33407
TG Therapeutics Investigational Trial Site Albany Georgia 31701
TG Therapeutics Investigational Trial Site Macon Georgia 31201
TG Therapeutics Investigational Trial Site Marietta Georgia 30060
TG Therapeutics Investigational Trial Site Chicago Illinois 60612
TG Therapeutics Investigational Trial Site Chicago Illinois 60637
TG Therapeutics Investigational Trial Site Decatur Illinois 62526
TG Therapeutics Investigational Trial Site Evanston Illinois 60201
TG Therapeutics Investigational Trial Site Harvey Illinois 60426
TG Therapeutics Investigational Trial Site Maywood Illinois 60153
TG Therapeutics Investigational Trial Site Niles Illinois 60714
TG Therapeutics Investigational Trial Site Peoria Illinois 61615
TG Therapeutics Investigational Trial Site Swansea Illinois 62226
TG Therapeutics Investigational Trial Site Fort Wayne Indiana 46845
TG Therapeutics Investigational Trial Site Indianapolis Indiana 46237
TG Therapeutics Investigational Trial Site Westwood Kansas 66210
TG Therapeutics Investigational Trial Site Louisville Kentucky 40207
TG Therapeutics Investigational Trial Site Covington Louisiana 70433
TG Therapeutics Investigational Trial Site Brewer Maine 04412
TG Therapeutics Investigational Trial Site Baltimore Maryland 21201
TG Therapeutics Investigational Trial Site Bethesda Maryland 20817
TG Therapeutics Investigational Trial Site Columbia Maryland 21044
TG Therapeutics Investigational Trial Site Towson Maryland 21204
TG Therapeutics Investigational Trial Site Ann Arbor Michigan 48109
TG Therapeutics Investigational Trial Site Duluth Minnesota 55805
TG Therapeutics Investigational Trial Site Saint Louis Park Minnesota 55416
TG Therapeutics Investigational Trial Site Columbia Missouri 65212
TG Therapeutics Investigational Trial Site Kansas City Missouri 64132
TG Therapeutics Investigational Trial Site St Louis Missouri 63110
TG Therapeutics Investigational Trial Site Billings Montana 59102
TG Therapeutics Investigational Trial Site Lincoln Nebraska 68510
TG Therapeutics Investigational Trial Site Omaha Nebraska 68130
TG Therapeutics Investigational Trial Site Lebanon New Hampshire 03756
TG Therapeutics Investigational Trial Site Hackensack New Jersey 07601
TG Therapeutics Investigational Trial Site Morristown New Jersey 07962
TG Therapeutics Investigational Trial Site Mount Holly New Jersey 08060
TG Therapeutics Investigational Trial Site Farmington New Mexico 87401
TG Therapeutics Investigational Trial Site Buffalo New York 14263
TG Therapeutics Investigational Trial Site New York New York 10019
TG Therapeutics Investigational Trial Site Syracuse New York 13210
TG Therapeutics Investigational Trial Site The Bronx New York 10467
TG Therapeutics Investigational Trial Site Charlotte North Carolina 28201
TG Therapeutics Investigational Trial Site Durham North Carolina 27705
TG Therapeutics Investigational Trial Site Hickory North Carolina 28602
TG Therapeutics Investigational Trial Site Kinston North Carolina 28501
TG Therapeutics Investigational Trial Site Raleigh North Carolina 27607
TG Therapeutics Investigational Trial Site Washington North Carolina 27889
TG Therapeutics Investigational Trial Site Canton Ohio 44718
TG Therapeutics Investigational Trial Site Cincinnati Ohio 45220
TG Therapeutics Investigational Trial Site Cincinnati Ohio 45242
TG Therapeutics Investigational Trial Site Cleveland Ohio 44106
TG Therapeutics Investigational Trial Site Columbus Ohio 43219
TG Therapeutics Investigational Trial Site Toledo Ohio 43623
TG Therapeutics Investigational Trial Site Portland Oregon 97213
TG Therapeutics Investigational Trial Site Portland Oregon 97227
TG Therapeutics Investigational Trial Site Springfield Oregon 97477
TG Therapeutics Investigational Trial Site Camp Hill Pennsylvania 17011
TG Therapeutics Investigational Trial Site Philadelphia Pennsylvania 19106
TG Therapeutics Investigational Trial Site Providence Rhode Island 02906
TG Therapeutics Investigational Trial Site Greenville South Carolina 29615
TG Therapeutics Investigational Trial Site Sioux Falls South Dakota 57105
TG Therapeutics Investigational Trial Site Watertown South Dakota 57201
TG Therapeutics Investigational Trial Site Chattanooga Tennessee 37404
TG Therapeutics Investigational Trial Site Kingsport Tennessee 37660
TG Therapeutics Investigational Trial Site Knoxville Tennessee 37916
TG Therapeutics Investigational Trial Site Memphis Tennessee 38120
TG Therapeutics Investigational Trial Site Austin Texas 78705
TG Therapeutics Investigational Trial Site Dallas Texas 75390
TG Therapeutics Investigational Trial Site Fort Sam Houston Texas 78234
TG Therapeutics Investigational Trial Site Houston Texas 77030
TG Therapeutics Investigational Trial Site San Antonio Texas 78130
TG Therapeutics Investigational Trial Site San Antonio Texas 78217
TG Therapeutics Investigational Trial Site San Antonio Texas 78229
TG Therapeutics Investigational Trial Site Tyler Texas 75702
TG Therapeutics Investigational Trial Site Ogden Utah 84403
TG Therapeutics Investigational Trial Site Blacksburg Virginia 24060
TG Therapeutics Investigational Trial Site Newport News Virginia 23601
TG Therapeutics Investigational Trial Site Olympia Washington 98502
TG Therapeutics Investigational Trial Site Seattle Washington 98104
TG Therapeutics Investigational Trial Site Seattle Washington 98108
TG Therapeutics Investigational Trial Site Seattle Washington 98109
TG Therapeutics Investigational Trial Site Spokane Washington 99216
TG Therapeutics Investigational Trial Site Vancouver Washington 97277
TG Therapeutics Investigational Trial Site Madison Wisconsin 53792
TG Therapeutics Investigational Trial Site Wauwatosa Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 57 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02793583, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 20, 2022 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02793583 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →